Integra LifeSciences Holdings
Financial ratios & Valuation

Forward Multiples (2025 – 2027)

202520262027
Price/Earnings ratio
7.947.102.88
Price/Sales ratio
0.700.670.63
Earnings per Share (EPS)
$1.85$2.07$5.09

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
52.21-711.5442.9857.9561.4699.4141.0433.5525.7750.2527.0299.41
Price/Sales ratio
1.912.833.233.152.533.284.003.672.982.203.132.53
Price/Book Value ratio
2.523.333.813.892.713.523.623.362.572.142.703.52
Price/Cash Flow ratio
22.3426.5027.5332.7518.7113.3526.9618.1617.5924.3218.4418.44
Price/Free Cash Flow ratio
47.9041.0046.3952.8130.6420.8639.2621.4621.4046.5722.4422.44
Price/Earnings Growth ratio
-0.196.51-0.01-3.40-5.10-5.180.241.262.86-0.832.91-5.10
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
61.99%63.00%64.81%63.34%61.18%62.79%62.03%61.24%62.29%57.62%62.29%61.18%
Operating Profit Margin
7.06%9.01%11.62%3.77%7.53%11.79%11.03%12.78%15.33%7.23%15.33%7.53%
Pretax Profit Margin
4.62%6.87%9.11%0.95%3.89%3.96%6.81%13.91%13.73%5.25%13.73%3.89%
Net Profit Margin
3.66%-0.39%7.51%5.44%4.12%3.30%9.75%10.96%11.59%4.39%11.59%4.12%
Effective Tax Rate
20.88%88.70%17.52%-468.66%-5.91%16.47%-43.16%21.24%15.58%16.44%15.58%-5.91%
Return on Assets
2.15%-0.19%4.12%2.01%1.95%1.51%3.70%4.47%4.64%1.79%4.64%1.95%
Return On Equity
4.82%-0.46%8.88%6.72%4.41%3.54%8.83%10.03%10.00%4.26%10.61%4.41%
Return on Capital Employed
4.51%4.86%6.84%1.56%3.90%6.02%4.70%5.72%6.69%3.20%6.69%3.90%
Liquidity Ratios
Current Ratio
4.203.154.002.352.952.593.08N/AN/AN/A3.612.95
Quick Ratio
2.311.632.241.501.881.632.312.452.602.172.241.88
Cash ratio
0.570.340.820.500.520.601.171.511.420.901.420.52
Days of Sales Outstanding
51.8654.6854.5177.3465.8766.2160.0054.8561.7361.4061.7366.21
Days of Inventory outstanding
245.31236.32227.16248.35179.05204.29217.32193.78201.70217.71201.70179.05
Operating Cycle
297.18291.00281.68325.70244.92270.50277.33248.64263.44279.11216.92270.50
Days of Payables Outstanding
35.2338.8630.3878.7548.5773.0938.2637.7563.4451.5963.4448.57
Cash Conversion Cycle
261.94252.14251.30246.94196.35197.40239.06210.88199.99227.5248.02197.40
Debt Ratios
Debt Ratio
0.390.400.360.570.430.400.420.410.370.390.530.43
Debt Equity Ratio
0.890.950.791.910.980.951.020.920.800.941.150.98
Long-term Debt to Capitalization
0.470.480.440.640.490.470.480.470.430.480.460.47
Total Debt to Capitalization
0.470.480.440.650.490.480.500.480.440.480.470.48
Interest Coverage Ratio
2.983.384.471.271.712.942.11N/AN/AN/A4.811.71
Cash Flow to Debt Ratio
0.120.130.170.060.140.270.130.200.180.090.160.14
Company Equity Multiplier
2.242.362.153.332.252.332.382.242.152.382.152.33
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
0.080.100.110.090.130.240.140.200.160.090.160.13
Free Cash Flow / Operating Cash Flow Ratio
0.460.640.590.620.610.630.680.840.820.520.820.61
Cash Flow Coverage Ratio
0.120.130.170.060.140.270.130.200.180.090.160.14
Short Term Coverage Ratio
21.196.57N/A1.908.876.521.395.225.019.635.016.52
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A